{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T03:45:01Z","timestamp":1778039101567,"version":"3.51.4"},"reference-count":76,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Merck Sharp & Dohme LLC"},{"name":"Merck & Co., Inc., Rahway, NJ, USA"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/14760584.2024.2322543","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T14:59:35Z","timestamp":1709132375000},"page":"312-323","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Cost-effectiveness of nonavalent HPV vaccination in the Netherlands"],"prefix":"10.1080","volume":"23","author":[{"given":"Cody","family":"Palmer","sequence":"first","affiliation":[{"name":"Inc","place":["Rahway, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiaan","family":"Dolk","sequence":"additional","affiliation":[{"name":"MSD","place":["Haarlem, the Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugne","family":"Sabale","sequence":"additional","affiliation":[{"name":"MSD","place":["Vilnius, Lithuania"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Merck & Co, Inc","place":["Rahway, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal","family":"Saxena","sequence":"additional","affiliation":[{"name":"Merck & Co, Inc","place":["Rahway, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,3]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13020243"},{"key":"e_1_3_7_4_1","unstructured":"Health council of the Netherlands. Vaccination against cervical cancer 2008. Available from: https:\/\/www.gezondheidsraad.nl\/documenten\/adviezen\/2008\/04\/01\/vaccinatie-tegen-baarmoederhalskanker"},{"key":"e_1_3_7_5_1","unstructured":"Schurink T de Melker H. HPV vaccination: background information for the Dutch Health Council. Rijksinstituut voor Volksgezondheid en Milieu. 2017. https:\/\/www.rivm.nl\/bibliotheek\/rapporten\/2017-0020.pdf"},{"key":"e_1_3_7_6_1","unstructured":"European Medicines Agency. Cervarix. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/cervarix"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70230-8"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021641"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.12.007"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28963"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.07.018"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv403"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.06.033"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.05.061"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30298-3"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02178-4"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw354"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.17615"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l1161"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25887"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2016"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1256778"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.29137"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0000000000000208"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.08.043"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10701"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.05.031"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2022.101872"},{"key":"e_1_3_7_29_1","unstructured":"Health Council of the Netherlands. Vaccination against HPV. Available from: https:\/\/www.healthcouncil.nl\/documents\/advisory-reports\/2019\/06\/19\/vaccination-against-hpv"},{"key":"e_1_3_7_30_1","unstructured":"National Institute for Public Health and the Environment. More than two million invitations to get vaccinated against HPV in 2023 2023. Available from: https:\/\/www.rivm.nl\/en\/news\/more-than-two-million-invitations-to-get-vaccinated-against-hpv-in-2023"},{"key":"e_1_3_7_31_1","unstructured":"Bruni L Albero G Serrano B et al. ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Netherlands. Summary Report. 2023 Mar 10 [cited 2024 Feb 27]. Available from: https:\/\/hpvcentre.net\/statistics\/reports\/NLD.pdf"},{"key":"e_1_3_7_32_1","volume-title":"Sexually transmitted infections in the Netherlands in 2019","author":"Staritsky LE","year":"2020","unstructured":"Staritsky LE, van Aar F, Visser M, et al. Sexually transmitted infections in the Netherlands in 2019. the Netherlands: National Institute for Public Health and the Environment; 2020 [cited 2024 Feb 27]. Available from:https:\/\/www.rivm.nl\/bibliotheek\/rapporten\/2020-0052.pdf"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106399"},{"key":"e_1_3_7_34_1","volume-title":"Accelerating the elimination of cervical cancer as a global public health problem","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Accelerating the elimination of cervical cancer as a global public health problem. World Health Organization. 2019 [cited 2024 Feb 27]. Available from:https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/EB146\/B146_9-en.pdf"},{"key":"e_1_3_7_35_1","volume-title":"Vaccinatiegraad en jaarverslag: Rijksvaccinatieprogramma Nederland 2021","author":"van Lier EA","year":"2022","unstructured":"van Lier EA, Oomen PJ, Giesbers H, et al. Vaccinatiegraad en jaarverslag: Rijksvaccinatieprogramma Nederland 2021. Nederland: Rijksinstituut voor Volksgezondheid en Milieu; 2022 [cited 2024 Feb 27]. Available from: https:\/\/www.rivm.nl\/bibliotheek\/rapporten\/2022-0017.pdf"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1086\/590560"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1086\/597071"},{"key":"e_1_3_7_38_1","unstructured":"European Medicines Agency. Gardasil. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/gardasil"},{"key":"e_1_3_7_39_1","unstructured":"European Medicines Agency. Gardasil 9. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/gardasil-9"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.11.076"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1086\/597309"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-017-0625-z"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2016.1208087"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.15106"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-75"},{"key":"e_1_3_7_46_1","unstructured":"National Institute for Public Health and the Environment. Newsletter: Dutch population screening for cervical cancer 2022. 2022 [cited 2024 Feb 27]. Available from: https:\/\/www.rivm.nl\/sites\/default\/files\/2023-01\/Newsletter%20Dutch%20population%20screening%20for%20cervical%20cancer%202022%20DEF2.pdf"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16400"},{"key":"e_1_3_7_48_1","unstructured":"Hakkaart-van Roijen L van der Linden N Bouwmans C et al. Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg. Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg Zorginstituut Nederland. 2015 [cited 2024 Feb 27]. Available from: https:\/\/www.zorginstituutnederland.nl\/binaries\/zinl\/documenten\/publicatie\/2016\/02\/29\/richtlijn-voor-het-uitvoeren-van-economische-evaluaties-in-de-gezondheidszorg\/richtlijn-voor-het-uitvoeren-van-economische-evaluaties-in-de-gezondheidszorg.pdf"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879\u2013020\u201305632\u20130"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1852870"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2008.01743.x"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.08.030"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1301.060438"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11538-008-9338-x"},{"key":"e_1_3_7_55_1","unstructured":"National Institute for Public Health and the Environment. Cervical cancer population screening in the Netherlands: factsheet 2021. 2021 [cited 2024 Feb 27]. Available from: https:\/\/www.rivm.nl\/sites\/default\/files\/2022-03\/013673%20Factsheet%20Cervical%20Cancer%20Screening.pdf"},{"key":"e_1_3_7_56_1","unstructured":"Rijksinstituut voor Volksgezondheid en Milieu. monitor bevolkingsonderzoek baarmoederhalskanker 2018. 2019. Available from: https:\/\/www.rivm.nl\/sites\/default\/files\/2019-12\/Monitor%20BMHK%202018.pdf"},{"key":"e_1_3_7_57_1","unstructured":"United Nations Statistics Division. Demographic Yearbook \u2013 2019. 2019. Available from: https:\/\/unstats.un.org\/unsd\/demographic-social\/products\/dyb\/dyb_2019\/"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0025-5564(97)00014-x"},{"key":"e_1_3_7_59_1","unstructured":"de Graaf H Wijsen C. Sexuele Gezondheid in Nederland 2017. 2017 [cited2024 Feb 27]. Available from: https:\/\/rutgers.nl\/wp-content\/uploads\/2021\/03\/Seksuele-Gezondheid-in-Nederland-2017.pdf"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.1993.0143"},{"key":"e_1_3_7_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62035-8"},{"key":"e_1_3_7_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0412.2011.01309.x"},{"key":"e_1_3_7_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60852-6"},{"key":"e_1_3_7_64_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061760"},{"key":"e_1_3_7_65_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909537"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1405044"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60777-6"},{"key":"e_1_3_7_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010971"},{"key":"e_1_3_7_69_1","unstructured":"Rijksinstituut voor Volksgezondheid en Milieu. Vaccinatiegraad en jaarverslag Rijksvaccinatieprogramma Nederland 2018 2019. Available from: https:\/\/www.rivm.nl\/publicaties\/vaccinatiegraad-en-jaarverslag-rijksvaccinatieprogramma-nederland-2018"},{"key":"e_1_3_7_70_1","unstructured":"Medicijnkosten.nl. GARDASIL 9 INJSUSP WWSP 0 5ML. Available from: https:\/\/www.medicijnkosten.nl\/medicijn?artikel=GARDASIL+9+INJSUSP+WWSP+0%2C5ML&id=fc25241a7318c7a927bd91e42edf846f"},{"key":"e_1_3_7_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-7596-1"},{"key":"e_1_3_7_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.06.044"},{"key":"e_1_3_7_73_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix272"},{"key":"e_1_3_7_74_1","unstructured":"Ministry of Finance. 3.1 Article 1 public health 2022. Available from: https:\/\/www.rijksfinancien.nl\/memorie-van-toelichting\/2022\/1SUPP\/XVI\/onderdeel\/1276156"},{"key":"e_1_3_7_75_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00591-14"},{"key":"e_1_3_7_76_1","doi-asserted-by":"publisher","DOI":"10.1201\/9781482296426"},{"key":"e_1_3_7_77_1","unstructured":"Zwaap J Knies S van der Meijden C et al. Kosteneffectiviteit in de praktijk Zorginstituut Nederland. 2015 [cited 2024 Feb 27]. Available from: https:\/\/www.zorginstituutnederland.nl\/publicaties\/rapport\/2015\/06\/26\/kosteneffectiviteit-in-de-praktijk"},{"key":"e_1_3_7_78_1","unstructured":"Statista. Gross domestic product (GDP) per capita in the Netherlands from 1960 to 2021 2022. Available from: https:\/\/www.statista.com\/statistics\/530398\/netherlands-gdp-per-capita\/"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2024.2322543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:44:06Z","timestamp":1759830246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2024.2322543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/14760584.2024.2322543"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2024.2322543","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-12-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}